Cargando…
Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme
BACKGROUND: Accumulating evidence demonstrates the oncogenic roles of lncRNA (long non-coding RNA) molecules in a wide variety of cancer types including glioma. Equally important, However, tumorigenic functions of lncRNA in glioma remain largely unclear. A recent study suggested lncRNA SNHG15 played...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714301/ https://www.ncbi.nlm.nih.gov/pubmed/31462285 http://dx.doi.org/10.1186/s13046-019-1371-0 |
_version_ | 1783447036695150592 |
---|---|
author | Li, Zhenzhe Zhang, Jixing Zheng, Hongshan Li, Chenlong Xiong, Jinsheng Wang, Weiliang Bao, Hongbo Jin, Hua Liang, Peng |
author_facet | Li, Zhenzhe Zhang, Jixing Zheng, Hongshan Li, Chenlong Xiong, Jinsheng Wang, Weiliang Bao, Hongbo Jin, Hua Liang, Peng |
author_sort | Li, Zhenzhe |
collection | PubMed |
description | BACKGROUND: Accumulating evidence demonstrates the oncogenic roles of lncRNA (long non-coding RNA) molecules in a wide variety of cancer types including glioma. Equally important, However, tumorigenic functions of lncRNA in glioma remain largely unclear. A recent study suggested lncRNA SNHG15 played a role for regulating angiogenesis in glioma but its role in the tumor microenvironment (TME) was not investigated. METHODS: First, we showed that SNHG15 was upregulated in GBM cells and associated with a poor prognosis for the patients of GBM using public databases. Next, we collected temozolomide sensitive (TMZ-S) and resistant (TMZ-R) clinical samples and demonstrated that co-culturing TMZ-R cells with HMC3 (microglial) cells promoted M2-polarization of HMC3 and the secretion of pro-GBM cytokines TGF-β and IL-6. RESULTS: Comparative qPCR analysis of TMZ-S and TMZ-R cells showed that a significantly higher level of SNHG15, coincidental with a higher level of Sox2, β-catenin, EGFR, and CDK6 in TMZ-R cells. Subsequently, using bioinformatics tool, a potential mechanistic route for SNHG15 to promote GBM tumorigenesis was by inhibiting tumor suppressor, miR-627-5p which leads to activation of CDK6. Gene-silencing technique was employed to demonstrate that suppression of SNHG15 indeed led to the suppression of GBM tumorigenesis, accompanied by an increase miR-627-5p and decreased its two oncogenic targets, CDK6 and SOX-2. In addition, SNHG15-silenced TMZ-R cells became significantly sensitive towards TMZ treatment and less capable of promoting M2-phenotype in the HMC3 microglial cells. We then evaluated the potential anti-GBM activity of CDK6 inhibitor, palbociclib, using TMZ-R PDX mouse models. Palbociclib treatment significantly reduced tumorigenesis in TMZ-R/HMC3 bearing mice and SNHG15 and CDK6 expression was significantly reduced while miR-627-5p level was increased. Additionally, palbociclib treatment appeared to overcome TMZ resistance as well as reduced M2 markers in HMC3 cells. CONCLUSION: Together, we provided evidence supporting the usage of CDK6 inhibitor for TMZ-resistant GBM cases. Further investigation is warranted for the consideration of clinical trials. GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1371-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6714301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67143012019-09-04 Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme Li, Zhenzhe Zhang, Jixing Zheng, Hongshan Li, Chenlong Xiong, Jinsheng Wang, Weiliang Bao, Hongbo Jin, Hua Liang, Peng J Exp Clin Cancer Res Research BACKGROUND: Accumulating evidence demonstrates the oncogenic roles of lncRNA (long non-coding RNA) molecules in a wide variety of cancer types including glioma. Equally important, However, tumorigenic functions of lncRNA in glioma remain largely unclear. A recent study suggested lncRNA SNHG15 played a role for regulating angiogenesis in glioma but its role in the tumor microenvironment (TME) was not investigated. METHODS: First, we showed that SNHG15 was upregulated in GBM cells and associated with a poor prognosis for the patients of GBM using public databases. Next, we collected temozolomide sensitive (TMZ-S) and resistant (TMZ-R) clinical samples and demonstrated that co-culturing TMZ-R cells with HMC3 (microglial) cells promoted M2-polarization of HMC3 and the secretion of pro-GBM cytokines TGF-β and IL-6. RESULTS: Comparative qPCR analysis of TMZ-S and TMZ-R cells showed that a significantly higher level of SNHG15, coincidental with a higher level of Sox2, β-catenin, EGFR, and CDK6 in TMZ-R cells. Subsequently, using bioinformatics tool, a potential mechanistic route for SNHG15 to promote GBM tumorigenesis was by inhibiting tumor suppressor, miR-627-5p which leads to activation of CDK6. Gene-silencing technique was employed to demonstrate that suppression of SNHG15 indeed led to the suppression of GBM tumorigenesis, accompanied by an increase miR-627-5p and decreased its two oncogenic targets, CDK6 and SOX-2. In addition, SNHG15-silenced TMZ-R cells became significantly sensitive towards TMZ treatment and less capable of promoting M2-phenotype in the HMC3 microglial cells. We then evaluated the potential anti-GBM activity of CDK6 inhibitor, palbociclib, using TMZ-R PDX mouse models. Palbociclib treatment significantly reduced tumorigenesis in TMZ-R/HMC3 bearing mice and SNHG15 and CDK6 expression was significantly reduced while miR-627-5p level was increased. Additionally, palbociclib treatment appeared to overcome TMZ resistance as well as reduced M2 markers in HMC3 cells. CONCLUSION: Together, we provided evidence supporting the usage of CDK6 inhibitor for TMZ-resistant GBM cases. Further investigation is warranted for the consideration of clinical trials. GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1371-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-28 /pmc/articles/PMC6714301/ /pubmed/31462285 http://dx.doi.org/10.1186/s13046-019-1371-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Li, Zhenzhe Zhang, Jixing Zheng, Hongshan Li, Chenlong Xiong, Jinsheng Wang, Weiliang Bao, Hongbo Jin, Hua Liang, Peng Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme |
title | Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme |
title_full | Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme |
title_fullStr | Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme |
title_full_unstemmed | Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme |
title_short | Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme |
title_sort | modulating lncrna snhg15/cdk6/mir-627 circuit by palbociclib, overcomes temozolomide resistance and reduces m2-polarization of glioma associated microglia in glioblastoma multiforme |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714301/ https://www.ncbi.nlm.nih.gov/pubmed/31462285 http://dx.doi.org/10.1186/s13046-019-1371-0 |
work_keys_str_mv | AT lizhenzhe modulatinglncrnasnhg15cdk6mir627circuitbypalbociclibovercomestemozolomideresistanceandreducesm2polarizationofgliomaassociatedmicrogliainglioblastomamultiforme AT zhangjixing modulatinglncrnasnhg15cdk6mir627circuitbypalbociclibovercomestemozolomideresistanceandreducesm2polarizationofgliomaassociatedmicrogliainglioblastomamultiforme AT zhenghongshan modulatinglncrnasnhg15cdk6mir627circuitbypalbociclibovercomestemozolomideresistanceandreducesm2polarizationofgliomaassociatedmicrogliainglioblastomamultiforme AT lichenlong modulatinglncrnasnhg15cdk6mir627circuitbypalbociclibovercomestemozolomideresistanceandreducesm2polarizationofgliomaassociatedmicrogliainglioblastomamultiforme AT xiongjinsheng modulatinglncrnasnhg15cdk6mir627circuitbypalbociclibovercomestemozolomideresistanceandreducesm2polarizationofgliomaassociatedmicrogliainglioblastomamultiforme AT wangweiliang modulatinglncrnasnhg15cdk6mir627circuitbypalbociclibovercomestemozolomideresistanceandreducesm2polarizationofgliomaassociatedmicrogliainglioblastomamultiforme AT baohongbo modulatinglncrnasnhg15cdk6mir627circuitbypalbociclibovercomestemozolomideresistanceandreducesm2polarizationofgliomaassociatedmicrogliainglioblastomamultiforme AT jinhua modulatinglncrnasnhg15cdk6mir627circuitbypalbociclibovercomestemozolomideresistanceandreducesm2polarizationofgliomaassociatedmicrogliainglioblastomamultiforme AT liangpeng modulatinglncrnasnhg15cdk6mir627circuitbypalbociclibovercomestemozolomideresistanceandreducesm2polarizationofgliomaassociatedmicrogliainglioblastomamultiforme |